Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma

References

• Smits C, Swen SJ, Theo Goverts S, et al. Assessment of hearing in very young children receiving carboplatin for retinoblastoma. Eur J Cancer 2006;42:492–500.
   PubMed Web of Science ®Google Scholar
• Dimaras H, Kimani K, Dimba EAO, et al. Retinoblastoma. Lancet 2012;379:1436–1446.
   PubMed Web of Science ®Google Scholar
• Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009;93:1129–1131.
   PubMed Web of Science ®Google Scholar
• Houston SK, Murray TG, Wolfe SQ, et al. Current update on retinoblastoma. Int Ophthalmol Clin 2011;51:77–91.
   PubMedGoogle Scholar
• Moll AC, Kuik DJ, Bouter LM, et al. Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862–1995. Br J Ophthalmol 1997;81:559–562.
   PubMed Web of Science ®Google Scholar
• Seregard S, Lundell G, Svedberg H, et al. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis. Ophthalmology 2004;111:1228–1232.
   PubMed Web of Science ®Google Scholar
• MacCarthy A, Draper GJ, Steliarova-Foucher E, et al. Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System Project. Eur J Cancer 2006;42:2092–2102.
   Google Scholar
• MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma in Great Britain 1963–2002. Br J Ophthalmol 2009;93:33–37.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Krailo M, Frazier L, et al. Children’s Oncology Group’s 2013 blueprint for research: rare tumors. Pediatr Blood Cancer 2013;60:1016–1021.
   PubMed Web of Science ®Google Scholar
• Lin P, O’Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009;148:192–198.
   PubMed Web of Science ®Google Scholar
• Abramson DH. Retinoblastoma in the 20th century: past success and future challenges – the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2005;46:2683–2691.
   PubMed Web of Science ®Google Scholar
• Sachdeva UM, O’Brien JM. Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J Clin Invest 2012;122:425–434.
   PubMed Web of Science ®Google Scholar
• Fallaha N, Dubois J, Carret AS, et al. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma. Arch Ophthalmol 2012;130:1075–1077.
   PubMedGoogle Scholar
• Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12–17.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019–2025.
   PubMed Web of Science ®Google Scholar
• Kim JW, Abramson DH, Dunkel IJ. Current management strategies for intraocular retinoblastoma. Drugs 2007;67:2173–2185.
   PubMed Web of Science ®Google Scholar
• Brock P, Pritchard J, Bellman S, et al. Ototoxicity of high-dose cis-platinum in children. Med Pediatr Oncol 1988;16:368–369.
   PubMedGoogle Scholar
• Brock PR, Bellman SC, Yeomans EC, et al. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 1991;19:295–300.
   PubMedGoogle Scholar
• Yancey A, Harris MS, Egbelakin A, et al. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients. Pediatr Blood Cancer 2012;59:144–148.
   PubMed Web of Science ®Google Scholar
• Qaddoumi I, Bass JK, Wu J, et al. Carboplatin-associated ototoxicity in children with retinoblastoma. J Clin Oncol 2012;30:1034–1041.
   PubMed Web of Science ®Google Scholar
• Fausti SA, Larson VD, Noffsinger D, et al. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear 1994;15:232–239.
   PubMed Web of Science ®Google Scholar
• Knight KRG, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 2005;23:8588–8596.
   PubMed Web of Science ®Google Scholar
• Brock PR, Knight KR, Freyer DR, et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 2012;30:2408–2417.
   PubMed Web of Science ®Google Scholar
• Bhagat SP, Bass JK, White ST, et al. Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastoma. Int J Pediatr Otorhinolaryngol 2010;74:1156–1163.
   PubMed Web of Science ®Google Scholar
• Jehanne M, Lumbroso-Le Rouic L, Savignoni A, et al. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 2009;52:637–643.
   PubMed Web of Science ®Google Scholar
• Pecora Liberman PH, Schultz C, Schmidt Goffi-Gomez MV, et al. Evaluation of ototoxicity in children treated for retinoblastoma: preliminary results of a systematic audiological evaluation. Clin Transl Oncol 2011;13:348–352.
   PubMed Web of Science ®Google Scholar
• Lambert MP, Shields C, Meadows AT. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 2008;50:223–226.
   PubMed Web of Science ®Google Scholar
• Lobarinas E, Salvi R, Ding D. Insensitivity of the audiogram to carboplatin induced inner hair cell loss in chinchillas. Hear Res 2013;302:113–120.
   PubMed Web of Science ®Google Scholar
• El-Badry MM, McFadden SL. Evaluation of inner hair cell and nerve fiber loss as sufficient pathologies underlying auditory neuropathy. Hear Res 2009;255:84–90.
   PubMed Web of Science ®Google Scholar
• Lerner SA, Matz GJ. Aminoglycoside ototoxicity. Am J Otolaryngol 1980;1:169–179.
   PubMedGoogle Scholar
• Dobie RA, Black FO, Pezsnecker SC, et al. Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy. Arch Otolaryngol Head Neck Surg 2006;132:253–257.
   PubMed Web of Science ®Google Scholar
• Levine DP. Vancomycin: a history. Clin Infect Dis 2006;42(Suppl. 1):S5–12.
   PubMed Web of Science ®Google Scholar
• Pussegoda K, Ross CJ, Visscher H, et al. Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clin Pharmacol Ther 2013;94:243–251.
   PubMed Web of Science ®Google Scholar
• Mukherjea D, Rybak LP. Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics 2011;12:1039–1050.
   PubMed Web of Science ®Google Scholar